ATE49885T1 - Avirulenter rabies-impfstoff. - Google Patents

Avirulenter rabies-impfstoff.

Info

Publication number
ATE49885T1
ATE49885T1 AT86400780T AT86400780T ATE49885T1 AT E49885 T1 ATE49885 T1 AT E49885T1 AT 86400780 T AT86400780 T AT 86400780T AT 86400780 T AT86400780 T AT 86400780T AT E49885 T1 ATE49885 T1 AT E49885T1
Authority
AT
Austria
Prior art keywords
rabies vaccine
avirulent
avirulent rabies
organismes
france
Prior art date
Application number
AT86400780T
Other languages
English (en)
Inventor
Anne Flamand
Patrice Coulon
Christophe Prehaud
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE49885T1 publication Critical patent/ATE49885T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT86400780T 1985-04-12 1986-04-11 Avirulenter rabies-impfstoff. ATE49885T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8505575A FR2580176B1 (fr) 1985-04-12 1985-04-12 Vaccin antirabique avirulent
EP86400780A EP0202142B1 (de) 1985-04-12 1986-04-11 Avirulenter Rabies-Impfstoff

Publications (1)

Publication Number Publication Date
ATE49885T1 true ATE49885T1 (de) 1990-02-15

Family

ID=9318198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86400780T ATE49885T1 (de) 1985-04-12 1986-04-11 Avirulenter rabies-impfstoff.

Country Status (4)

Country Link
EP (1) EP0202142B1 (de)
AT (1) ATE49885T1 (de)
DE (1) DE3668552D1 (de)
FR (1) FR2580176B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent
FR2693655B1 (fr) * 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
ATE356202T1 (de) * 1998-11-27 2007-03-15 Intervet Int Bv Attenuierte stabile tollwutvirusmutante und lebende impfstoffe

Also Published As

Publication number Publication date
DE3668552D1 (de) 1990-03-08
FR2580176A1 (fr) 1986-10-17
EP0202142B1 (de) 1990-01-31
FR2580176B1 (fr) 1988-02-26
EP0202142A1 (de) 1986-11-20

Similar Documents

Publication Publication Date Title
EP0179139A4 (de) Leukämieassoziiertes virusimmunogen, impfstoff und testverfahren.
NL194909B (nl) Werkwijze voor de bereiding van gepolymeriseerd hemoglobine en celvrij vervangingsmiddel voor rode bloedlichaampjes op basis daarvan.
IT8621232A0 (it) Copolimeri silitati dell'isobutilene reticolabili in condizioni ambientali eprocedimento per la loro preparazione.
FI911500A7 (fi) Uudet hiivakannat, menetelmä niiden valmistamiseksi ja niiden käyttö
DE3685764D1 (de) Antibiotikum hergestellt von lysobacter sp. sc 14,067.
FI945626A0 (fi) Menetelmä 2,2-difluoriketeenisilyyliasetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihappoestereiden valmistamiseksi
NL960005I2 (nl) Optisch zuivere verbinding, en werkwijze voor de bereiding daarvan.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
FI875684A7 (fi) 1,1,2,2-tetrahydroperfluorialkanolien ja niiden estereiden valmistusmenetelmä.
DE3668552D1 (de) Avirulenter rabies-impfstoff.
AU7890687A (en) DNA sequence vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of multiplying in CHO cells
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
ES506116A0 (es) Procedimiento para la obtencion de isomaltulosa a partir de sacarosa
DE68918649D1 (de) Lebende Newcastle-Krankheit-Virus-Vakzine.
FI873125A7 (fi) Menetelmä 5,6-substituoitujen 2,4-kinatsoliinidiamiinien valmistamiseksi sekä uudet välituotteet.
IT1218692B (it) Procedimento microbiologico per la preparazione di 9 alfa-idrossi-4-androstene-3,17 dione
FI883255L (fi) Maenniskans papillomavirus, typ 41 dess dna och av dna:et kodade protein.
DK642687D0 (da) N,n'-disubstituerede urinstoffer samt fremgangsmaade til fremstilling deraf
FI841094A7 (fi) Kantajaan sidottu virusantigeeni, sen valmistus ja käyttö.
IT8622780A0 (it) "2-cloro-12-(-3-dimetilammino-2-metilpropil)-12h-dibenzo-/d,g//1,3,6/d iossazocine otticamente attive eprocedimento per la loro preparazione.
AU591290B2 (en) Rapid detection of n. gonorrhoeae without culture
SU877368A1 (ru) Способ измерени силы
IT8720060A0 (it) Perfluoro 2,3,4-trimetilpentano eprocedimento per la sua preparazione.
FR2578424B1 (fr) Souches mutantes, vaccinantes de bacteries, leur procede d'obtention, et preparations vaccinales les contenant
EP0345559A3 (de) HIV-2-Varianten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee